Search by Drug Name or NDC

    NDC 00469-0625-99 Xtandi 40 mg/1 Details

    Xtandi 40 mg/1

    Xtandi is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Astellas Pharma US, Inc.. The primary component is ENZALUTAMIDE.

    Product Information

    NDC 00469-0625
    Product ID 0469-0625_bddcc9f9-afad-4b83-a6d7-551f3cfd9cdb
    Associated GPIs 21402430000320
    GCN Sequence Number 079974
    GCN Sequence Number Description enzalutamide TABLET 40 MG ORAL
    HIC3 V1J
    HIC3 Description ANTINEOPLASTIC - ANTIANDROGENIC AGENTS
    GCN 46626
    HICL Sequence Number 039580
    HICL Sequence Number Description ENZALUTAMIDE
    Brand/Generic Brand
    Proprietary Name Xtandi
    Proprietary Name Suffix n/a
    Non-Proprietary Name enzalutamide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 40
    Active Ingredient Units mg/1
    Substance Name ENZALUTAMIDE
    Labeler Name Astellas Pharma US, Inc.
    Pharmaceutical Class Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA213674
    Listing Certified Through 2024-12-31

    Package

    NDC 00469-0625-99 (00469062599)

    NDC Package Code 0469-0625-99
    Billing NDC 00469062599
    Package 1 BOTTLE in 1 CARTON (0469-0625-99) / 120 TABLET in 1 BOTTLE
    Marketing Start Date 2020-08-04
    NDC Exclude Flag N
    Pricing Information N/A